The global demand for GMP Cell Therapy Consumables Market is presumed to reach the market size of nearly USD 195.42 BN by 2028 from USD 21.03 BN in 2021 with a CAGR of 37.5% under the study period 2022 - 2028.
GMP cell therapy consumables refer to materials and products used in the production of cell-based therapies under Good Manufacturing Practices (GMP) conditions. GMP is a set of standards and guidelines established by agencies such as the FDA and the EMA to ensure the quality and safety of cell-based therapies. GMP cell therapy consumables include items such as cell culture media, reagents, sterile packaging, and processing equipment that are used to produce cell-based therapies in a controlled and regulated environment. These consumables play a critical role in ensuring the quality, safety, and efficacy of cell-based therapies, and are an important component of the cell therapy manufacturing process.
Advancements in cell therapy technology, such as the development of new and improved cell culture media, reagents, and processing equipment, are driving the GMP cell therapy consumables market as more cell-based therapies are developed and commercialized. The growing demand for cell-based therapies is driving the GMP cell therapy consumables market growth as more cell-based therapies are produced and used to treat a wide range of diseases and conditions. The increase in investment in cell therapy research is scaling up the growth of GMP cell therapy consumables market as more research is conducted to develop new and improved cell-based therapies. Stringent regulatory requirements, such as those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), are driving the demand for GMP cell therapy consumables as cell therapy manufacturers look to meet these requirements and produce high-quality, safe, and effective cell-based therapies. The increase in demand for personalized medicine is boosting the GMP cell therapy consumables market growth as cell-based therapies are used to treat patients based on their individual needs and genetic profiles. The growing awareness of the benefits of cell-based therapies, such as their potential to treat a wide range of diseases and conditions, is driving the demand for GMP cell therapy consumables as more people seek to benefit from these therapies. Advancements in bioprocessing technology, such as the development of new and improved bioreactors and bioprocessing equipment, are driving the growth of the GMP cell therapy consumables market as more cell-based therapies are produced in a controlled and regulated environment.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gmp cell therapy consumables. The growth and trends of gmp cell therapy consumables industry provide a holistic approach to this study.
This section of the gmp cell therapy consumables market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Cell Therapy
- Reagents/Molecular Biology Reagents
- Growth Factors/Cytokines And Interleukins
- NK Cell Therapy
- Stem Cell Therapy
- T-Cell Therapy
By End Use
- Cell Collection And Characterization/Sorting And Separation
- Cell Culture And Expansion/Preparation
- Cell Processing And Formulation
- Cell Isolation And Activation
- Cell Distribution/Handling
- Process Monitoring And Control/Readministration/Quality Assurance
This section covers the regional outlook, which accentuates current and future demand for the GMP Cell Therapy Consumables market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global GMP Cell Therapy Consumables Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gmp cell therapy consumables market include Sartorius AG, Thermo Fisher Scientific Inc, Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc, FUJIFILM Irvine Scientific Inc, Lonza Group AG, BPS Bioscience Inc, Merck KGaA, Global Life Sciences Solutions USA LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.